Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
38 Leser
Artikel bewerten:
(0)

Global Orthobiologics Market 2016-2020 - High Cost of Spine Fusion Surgery - Research and Markets

DUBLIN, May 20, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Orthobiologics Market 2016-2020" report to their offering.

The report forecasts the global orthobiologics market to grow at a CAGR of 7.03% during the period 2016-2020.

Orthobiologics is an advancing medical field that involves the use of biomaterials and cell-based therapies to repair broken bones, prevent bone degeneration, and provide bone stability. Innovations in orthobiologics led to the development of bone grafts and tissue regeneration products that accelerate the bone healing process, reducing hospital visits, and stays.

A major trend that is expected to boost the market growth during the forecast period is the increase in funds to enhance orthobiologics. Vendors in the market are extensively investing in research to develop a wide range of innovative products, strengthening their portfolio and successful commercialization of products. Such developments will lead to the growth of the orthobiologics market over the next five years.

According to the report, forming strategic partnerships for marketing is one of the primary drivers of the market. Vendors form strategic partnerships to expand their businesses, extend their product offerings, and increase their market shares. These partnerships also help companies align their technologies with each other's innovative medical device portfolio.

Further, the report states that the high cost of spinal fusion surgeries is restricting the sales of orthobiologics.

Key vendors:

  • DePuy Synthes
  • Medtronic
  • Sanofi
  • Stryker
  • Zimmer Biomet

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Funding for orthobiologics development

PART 06: Market landscape

PART 07: Market segmentation by product

PART 08: Market segmentation by procedure

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

For more information visit http://www.researchandmarkets.com/research/kc6x5s/global

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.